• Fri news: Gilead withdraws bladder cancer drug. Amgen and Intercept PDUFA date pushback. CVS replaces CEO. Supernus depression trial. AbbVie Parkinson’s approval. See more on our front page

Dan walk Robin out today!!!

anonymous

Guest
Dan, do the company a huge favor and walk Robin out of the building asap. Don't wait for a new CFO to be named, you will not notice the difference , other than an huge sigh of relief.
 












Dan, do the company a huge favor and walk Robin out of the building asap. Don't wait for a new CFO to be named, you will not notice the difference , other than an huge sigh of relief.

Robin is a useless suit who took credit for Gilead's early stock gains during the growth years, made $5MM/year minimum , collected wines, and pushed people around. What a waste of space.

Good riddance!